The aim of this prospective randomized controlled trial is to compare the two procedures One-anastomosis gastric Bypass/Mini-gastric Bypass (OAGB/MGB) and Roux-en Y gastric bypass (RYGB) in relation to intraoperative and postoperative complications (classification of Clavien-Dindo), mortality, metabolic impact (remission of type 2 diabetes mellitus, hypertonus, gastro-esophageal reflux disease, sleep apnea, dyslipidemia, quality of life, operation time, postoperative excess weight loss, malnutrition and re-do/revisonal surgery.
OAGB/MGB is gaining popularity as a primary surgical treatment for morbid obesity due to reduced operation time, a shorter learning curve, better weight loss, higher metabolic impact and fewer major complications compared to RYGB. In this prospective randomized controlled trial we want to compare OAGB/MGB and RYGB with a FU of up to 24 month. Patients with indication for gastric bypass get randomized in group A (RYGB, n = 50) or B (OAGB/MGB, n = 50). FU is performed 1, 3, 6, 12 and 24 month after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
100
Sana Klinikum Offenbach
Offenbach, Hesse, Germany
complications
complications classified next to Clavien-Dindo
Time frame: up to 2 years after surgery
mortality
death up to 2 years after surgery
Time frame: up to 2 years after surgery
remission of type 2 diabetes mellitus
HbA1c \< 6.5% without medication
Time frame: up to 2 years after surgery
remission of hypertonus
blood pressure \< 140/90 mmHg without medication
Time frame: up to 2 years after surgery
gastro-esophageal reflux disease
GERD-HRGL Heartburn Scale
Time frame: up to 2 years after surgery
remission of sleep apnea
presence/absence of CPAP
Time frame: up to 2 years after surgery
remission of hypertrigliceridemia
triglyceride \< 200mg/dl without medication
Time frame: up to 2 years after surgery
remission of hypercholesterinemia
cholesterin \< 155 mg/dl without medication
Time frame: up to 2 years after surgery
quality of life questionnaire
changing in quality of life measured by questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: up to 2 years after surgery
weight loss
postoperative excess weight loss in %
Time frame: up to 2 years after surgery
operation time
operation time during surgery in minutes
Time frame: operation time during surgery in minutes
malnutrition 1
postoperative malnutrition: protein \< 64 g/l
Time frame: up to 2 years after surgery
malnutrition 2
postoperative malnutrition: albumin \< 35 g/l
Time frame: up to 2 years after surgery
malnutrition 3
postoperative malnutrition: ferritin (\< 30 µg/l)
Time frame: up to 2 years after surgery
malnutrition 4
postoperative malnutrition: vitamin E \< 12 µmol/l
Time frame: up to 2 years after surgery
malnutrition 5
postoperative malnutrition: vitamin K \< 90 ng/l
Time frame: up to 2 years after surgery
malnutrition 6
postoperative malnutrition: vitamin 25-OH- Vitamin D3 \< 50 nmol/l
Time frame: up to 2 years after surgery
malnutrition 7
postoperative malnutrition: vitamin A \< 1.05 µmol/l
Time frame: up to 2 years after surgery
malnutrition 8
postoperative malnutrition: vitamin B12 \< 145 pmol/l
Time frame: up to 2 years after surgery
revisional surgery
revisional surgery during follow up
Time frame: up to 2 years after surgery